Cite
MLA Citation
Anthony R. Mato et al.. “Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced‐dose ibrutinib: results from a multi‐centre study.” British journal of haematology, vol. 181, 2018, pp. 259–261. http://access.bl.uk/ark:/81055/vdc_100060305440.0x00005e